Lilly Seeks EUA For COVID-19 Antibody, Unveils Positive Combo Data

 
• By Joseph Haas

Following last month’s data showing reduced hospitalization risk with single neutralizing antibody therapy, Lilly now has data showing a two-antibody combo reduces COVID-19 viral load significantly.

Corona patient
Lilly is seeking an FDA emergency use authorization for LY-CoV555

More from COVID-19

More from Scrip